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Same Dataset, Same 
Conclusion, Different in 
Detail
Who’s Doing What from 
Large Public Database?
To the Editor:
We read with great interest the 
article by yu et al.1 on the association of 
tuberculosis with lung cancer. This ret-
rospective cohort study indispensably 
proved the positive relationship, thanks 
to the nationwide scale and large number 
of cases they analyzed from the Taiwan 
National Health Insurance Database.
This administrative database has 
been widely used to produce scientific 
knowledge. From 2000 until 2009, no less 
than 383 articles have been published, and 
29 (7.5%) of them are related to cancer.2 
However, because it is publicly available, 
there is a chance that people from different 
groups work on the same topics from the 
same dataset at the same period. It coin-
cidentally occurred when similar research 
byWu et al.3 was published in the February 
2011 issue of Cancer journal (Epublication 
by September 30, 2010).
Although both longitudinal stud-
ies likewise showed the increased risk 
of lung cancer among patients with 
tuberculosis, they were different in 
defining eligibility, case and control 
group, and follow-up duration (Table 
1). This resulted in different incident 
rate ratio and hazard ratio. In this case, 
according to International Committee 
of Medical Journal Editors, “there may 
even be a good reason to publish more 
than one manuscript because different 
analytical approaches may be comple-
mentary and equally valid.”4 However, 
this implies readers, particularly those 
who perform meta-analysis, to care-
fully consider different approach used 
in those articles while taking into 
account their result.
With regard to more publication 
from the same dataset, Wright et al.5 have 
reported three groups working on similar 
topic from the same source: UK General 
Practice Research Database, another 
large public database in the world. Those 
groups are not known to each other 
before publication. Considering that it 
could recur, we propose to the owner 
of any large public database to develop 
a real-time tool to check who is doing 
what from that resource during publica-
tion process period. We believe that this 
tool will be of benefit to the research-
ers and substantially contribute to the 
knowledge discovery from that large 
database.
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TABLE 1. Comparison of Two Articles on Tuberculosis with Lung Cancer
 Article by Yu et al. Article by Wu et al.
Dataset
 Source and number of 
original record
one million individuals from National Health Insurance Research 
Database, 5% of total health insurance members in Taiwan
Methods
 Eligibility (number) Individuals without 
cancer (716,872)
All NHIRD individuals (1,000,000)
 TB case definition ICD-9-CM code 011 and 
A code A020
ICD-9-CM code 010–012, 018 or A-code 
A020, A021 plus prescriptions of at least 
two antituberculosis medications for >28 d
 No. of cases 4480 5657
 Control definition All non-TB cases Four non-TB cases matched to 1 TB case by 
age and sex
 No. of controls 712,392 23,984
 Lung cancer definition ICD-9-CM code 162 or 
A code A101
ICD-9-CM code 162 or A code A101
 Follow-up (yr) 7–9 1–12
Results
 Incident rate ratio (CI) 10.9 (NA) 1.76 (1.33–2.32)
 Hazard ratio (CI) 3.32 (2.70–4.09) 1.64 (1.24–2.15)
Conclusion Increased lung cancer among individuals with pulmonary TB
TB, tuberculosis; NHIRD, National Health Insurance Research Database; CI, confidence interval.
